Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · August 21, 2024

Plasma Biomarkers of Neurodegeneration in Individuals With or at a High Risk for Lewy Body Disease

NPJ Parkinson's Disease

 

Additional Info

Disclosure statements are available on the authors' profiles:

NPJ Parkinson's Disease
Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body disease
NPJ Parkinsons Dis 2024 Jul 31;10(1)135, K Hiraga, M Hattori, Y Satake, D Tamakoshi, T Fukushima, T Uematsu, T Tsuboi, M Sato, K Yokoi, K Suzuki, Y Arahata, Y Washimi, A Hori, M Yamamoto, H Shimizu, M Wakai, H Tatebe, T Tokuda, A Nakamura, S Niida, M Katsuno

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading